GLP-1 dosage for weight loss: how titration actually works. - Reddit

Why does GLP-1 dose matter more than which brand you take?

GLP-1 receptor agonists work by binding to GLP-1 receptors in the gut, pancreas, and brain. The receptor engagement drives satiety signaling, slows gastric emptying, and reduces caloric intake by dampening appetite. But the magnitude of that effect scales with plasma concentration — which is determined directly by dose.

This is why dosing is not an afterthought in GLP-1 protocols. Getting the dose right is the core of a successful weight management plan. Too low and the appetite signal is insufficient. Too high, too fast, and nausea and GI discomfort derail adherence entirely — which defeats the purpose.

Titration exists to thread that needle. It is not a delay tactic; it is how the protocol works.

What is the standard semaglutide titration ladder?

Compounded semaglutide prescribed through clinician-supervised telehealth programs follows a titration approach modeled on the dose-escalation schedules validated in clinical research. A common protocol structure looks like this:

• Weeks 1–4: 0.25 mg weekly. The introductory dose. The goal is tolerability, not measurable weight change. Most patients experience mild GI adjustment at this stage.
• Weeks 5–8: 0.5 mg weekly. The first therapeutic tier. Appetite suppression typically becomes noticeable here.
• Weeks 9–12: 1.0 mg weekly. A clinically meaningful dose. Many patients see sustained results at this level and remain here.
• Weeks 13–16+: 1.7 mg or 2.4 mg weekly if clinician-directed. Higher doses are available where response plateaus and tolerance is established.

Your clinician may adjust this schedule based on how you respond. If side effects are significant at a given step, they may hold you at that level longer before advancing. If you are tolerating each increase well and progress is on track, some protocols move faster.

Note: compounded semaglutide from licensed 503A pharmacies is patient-specific and dosed in milligrams by your clinician — not a fixed-dose pen from a commercial manufacturer. No hidden overseas supply chain. Compounded in the USA by licensed 503A pharmacies.

How is tirzepatide dosing different?

Tirzepatide is a GIP and GLP-1 dual receptor agonist. Its titration ladder is structured similarly, but the doses are different because the compound has a different potency profile.

• Month 1: 2.5 mg weekly. Starting dose for tolerability establishment.
• Month 2: 5 mg weekly. First increase; typically the first level where meaningful appetite reduction is felt.
• Month 3–4: 7.5 mg weekly. Mid-range; many patients see strong results at this tier.
• Month 5–6+: 10 mg, 12.5 mg, or 15 mg weekly if clinician-directed and tolerated. SURMOUNT-1 trial data showed the highest average weight reduction at the 15 mg dose — but not every patient needs or tolerates the maximum.

The dual GIP/GLP-1 mechanism of tirzepatide appears to produce stronger appetite suppression than semaglutide alone at equivalent tolerability for many patients, though individual response varies considerably.

What does “maintenance dose” mean in practice?

Maintenance dose does not mean maximum dose. It means the dose at which your appetite signal is sufficiently managed to support your weight management goals with an acceptable side effect profile. For some patients that is 1 mg semaglutide. For others it is 2.4 mg. There is no single right answer.

Clinicians following evidence-based protocols look for the lowest effective maintenance dose — the minimum dose at which you sustain progress — rather than automatically escalating to the ceiling. This approach tends to improve long-term adherence and reduces the likelihood of side effects becoming a reason to stop.

Once weight management goals are reached, some patients transition to an even lower maintenance dose designed to sustain results rather than drive further reduction. This is an individual clinical decision.

How are side effects handled during dose adjustment?

GI side effects — nausea, delayed gastric emptying, occasional vomiting — are the most common reason patients struggle with titration. They are dose-dependent and typically most pronounced in the first few weeks after each increase.

If side effects at a given dose are significant, the standard approach is not to push through to the next increase on schedule. It is to hold at the current dose until those effects resolve, then reassess. Many clinicians will hold for an additional four weeks rather than advance if tolerance is not established.

In some cases, stepping back to the previous dose temporarily is appropriate. This is not a failure; it is the protocol doing what it is supposed to do.

What factors determine how your GLP-1 dose is set?

Clinicians setting GLP-1 dosage for weight loss consider several factors:

• Body weight and BMI: Starting weight influences how the protocol is calibrated, though it does not automatically determine the ceiling dose.
• Comorbidities and medical history: Existing GI conditions, history of pancreatitis, thyroid history, and other clinical factors all shape protocol design.
• Concurrent medications: Drug interactions — particularly with medications that affect gastric motility or glycemic regulation — influence dose decisions.
• Prior GLP-1 experience: Patients who have previously tolerated a GLP-1 at a given dose may not need to retitrate all the way from the start.
• Tolerance at each step: The most important input at every stage. Titration is adjusted to the individual, not imposed as a rigid schedule.

Why a clinician matters at every dose level

GLP-1 dosing decisions — starting dose, escalation timing, hold decisions, maintenance calibration — require clinical judgment. They are not one-size-fits-all and should not be self-directed from online charts.

A clinician-supervised program gives you a protocol tailored to your health history, monitors your response through check-ins, and adjusts the dose based on what is actually happening. That is different from purchasing a fixed-dose product and assuming the schedule applies to you.

Compounded semaglutide and tirzepatide through a licensed 503A pharmacy — where each dose is prepared specifically for you under physician supervision — is the standard for this kind of individualized protocol.

Learn more about how compounded semaglutide works or compounded tirzepatide under clinician supervision.

Frequently asked questions